免费注册|会员登录 优质供应商

☰ 导航
展台首页 公司简介 供应产品 产品分类 公司动态 技术文章 咨询留言 联系我们 资料下载

您的位置：阿仪网 > 生物试剂/抗体/细胞 > 生物制剂 > 免疫检测 > 沃卡威（北京）生物技术有限公司 > 产品展示 > 生物试剂 > invivo MAb anti-mouse CD45.2

联系我们

联系人：王蕾

点击查看联系方式

产品展示

invivo MAb anti-mouse CD45.2

invivo MAb anti-mouse CD45.2

点击次数：378

价格：￥电议

更新日期：2026/9/7 17:25:49

生 产 地：中国大陆

产品型号：

简单介绍：
MAb anti-mouse CD45.2 克隆：104.2
抗体类型:
Monoclonal Antibodies,货号: BE0300 品牌: Bioxcell 规格: mg

商家名片
王*
联系我时，请说明是阿仪网看到的，谢谢!
  • 电话: 17******084
  • 手机: 13******891
  • 微信: 17******084
  • 交换名片后展示联系方式 → →
相关标签：抗体,,Bioxcell,invivo,MAb,anti-mouse,

详细内容

概述
别名:
MAb anti-mouse CD45.2
克隆类型:
Monoclonal Antibodies，克隆：104.2，分子量：150KD，纯度：SDS-PAGE电泳纯度＞95
详述

MAb anti-mouse CD45.2免疫原为B10.S小鼠胸腺细胞和脾细胞，可应用于：流式细胞术，体内CD45.2阻断，体外CD45.2阻断，
免疫组织化学(冻)等

104.2单克隆抗体与小鼠CD45.2 (180-240 kDa的蛋白酪氨酸磷酸酶家族成员)反应。CD45.2是CD45的一种异体抗原，
仅在C57BL/6、CBA、129、A、AKR、C58、DBA/1、DBA/2、BALB/c和C3H/He等小鼠品系中表达。104.2单克隆抗体
不与表达cd45.1的小鼠菌株(包括DA、SJL/J、RIII和STS/A)的白细胞发生反应。CD45.2在除成熟红细胞和血小板外的
所有造血细胞上表达，被认为参与TCR和BCR信号转导。104.2抗体已被证明能在体外阻断B细胞反应，并在体内降
低slee易感小鼠的血清自身抗体浓度。

20多年来，科学家一直相信bioxcell是体内功能抗体的来源。我们牢记这一责任，始终致力于一个目标：生产高质量、价值高的抗体。
我们对科学家的坚定承诺激励我们创造和优化一种利的体内抗体制造方法，具有显著的优势，直接使我们的客户受益。

Bio X Cell产品特点：

我们优化的利抗体制造方法确保超纯抗体溶液不添加蛋白质或化学物质。使用SDS-PAGE对每个批次的纯度进行QC测试。

超低内毒素水平。我们的InVivoMAb产品≤2EU/mg，InVivoPlus产品≤1EU/mg。如果需要低于1EU/mg的内毒素水平，请联系我们的
技术支持以获取详细信息。










货号 名称 克隆 反应性 抗原 宿主 同型 免疫原
BE0300-100MG InVivoMAb anti-mouse CD45.2 104.2 mouse CD45.2 mouse IgG2a, κ B10.S mouse thymocytes ａnd splenocytes
BE0300-1MG InVivoMAb anti-mouse CD45.2 104.2 mouse CD45.2 mouse IgG2a, κ B10.S mouse thymocytes ａnd splenocytes
BE0300-5MG InVivoMAb anti-mouse CD45.2 104.2 mouse CD45.2 mouse IgG2a, κ B10.S mouse thymocytes ａnd splenocytes
BE0300-25MG InVivoMAb anti-mouse CD45.2 104.2 mouse CD45.2 mouse IgG2a, κ B10.S mouse thymocytes ａnd splenocytes
BE0300-50MG InVivoMAb anti-mouse CD45.2 104.2 mouse CD45.2 mouse IgG2a, κ B10.S mouse thymocytes ａnd splenocytes
BE0301-100MG InVivoMAb human IgG2 isotype control n/a n/a Unknown Specificify human IgG2
BE0301-1MG InVivoMAb human IgG2 isotype control n/a n/a Unknown Specificify human IgG2
BE0301-5MG InVivoMAb human IgG2 isotype control n/a n/a Unknown Specificify human IgG2
BE0301-25MG InVivoMAb human IgG2 isotype control n/a n/a Unknown Specificify human IgG2
BE0301-50MG InVivoMAb human IgG2 isotype control n/a n/a Unknown Specificify human IgG2
BE0302-100MG InVivoMAb anti-mouse CD20 AISB12 mouse CD20 rat IgG2a, κ Full length mouse CD20 protein
BE0302-25MG InVivoMAb anti-mouse CD20 AISB12 mouse CD20 rat IgG2a, κ Full length mouse CD20 protein
BE0302-50MG InVivoMAb anti-mouse CD20 AISB12 mouse CD20 rat IgG2a, κ Full length mouse CD20 protein
BE0303-100MG InVivoMAb anti-mouse IL-17F MM17F8F5.1A9 mouse IL-17F mouse IgG1, κ Mouse IL-17F
BE0303-1MG InVivoMAb anti-mouse IL-17F MM17F8F5.1A9 mouse IL-17F mouse IgG1, κ Mouse IL-17F
BE0303-5MG InVivoMAb anti-mouse IL-17F MM17F8F5.1A9 mouse IL-17F mouse IgG1, κ Mouse IL-17F
BE0303-25MG InVivoMAb anti-mouse IL-17F MM17F8F5.1A9 mouse IL-17F mouse IgG1, κ Mouse IL-17F
BE0303-50MG InVivoMAb anti-mouse IL-17F MM17F8F5.1A9 mouse IL-17F mouse IgG1, κ Mouse IL-17F
BE0304-100MG InVivoMAb anti-mouse BTLA (CD272) 6F7 mouse BTLA (CD272) mouse IgG1, κ Ig domain of C57BL/6 mouse BTLA
BE0304-1MG InVivoMAb anti-mouse BTLA (CD272) 6F7 mouse BTLA (CD272) mouse IgG1, κ Ig domain of C57BL/6 mouse BTLA
BE0304-5MG InVivoMAb anti-mouse BTLA (CD272) 6F7 mouse BTLA (CD272) mouse IgG1, κ Ig domain of C57BL/6 mouse BTLA
BE0304-25MG InVivoMAb anti-mouse BTLA (CD272) 6F7 mouse BTLA (CD272) mouse IgG1, κ Ig domain of C57BL/6 mouse BTLA
BE0304-50MG InVivoMAb anti-mouse BTLA (CD272) 6F7 mouse BTLA (CD272) mouse IgG1, κ Ig domain of C57BL/6 mouse BTLA
BE0305-100MG InVivoMAb anti-mouse CLEC9A (CD370) 7H11 mouse CLEC9A (CD370) Rat IgG1, κ RBL-2H3 cells expressing mouse CLEC9A fused to an HA epie
BE0305-1MG InVivoMAb anti-mouse CLEC9A (CD370) 7H11 mouse CLEC9A (CD370) Rat IgG1, κ RBL-2H3 cells expressing mouse CLEC9A fused to an HA epie
BE0305-5MG InVivoMAb anti-mouse CLEC9A (CD370) 7H11 mouse CLEC9A (CD370) Rat IgG1, κ RBL-2H3 cells expressing mouse CLEC9A fused to an HA epie
BE0305-25MG InVivoMAb anti-mouse CLEC9A (CD370) 7H11 mouse CLEC9A (CD370) Rat IgG1, κ RBL-2H3 cells expressing mouse CLEC9A fused to an HA epie
BE0305-50MG InVivoMAb anti-mouse CLEC9A (CD370) 7H11 mouse CLEC9A (CD370) Rat IgG1, κ RBL-2H3 cells expressing mouse CLEC9A fused to an HA epie
BE0306-100MG InVivoMAb anti-human/monkey MHC class II (HLA-DR) L243 human/monkey MHC class II (HLA-DR) Mouse IgG2a, κ Human lymphoblastoid B cell line RPMI 8866.9
BE0306-1MG InVivoMAb anti-human/monkey MHC class II (HLA-DR) L243 human/monkey MHC class II (HLA-DR) Mouse IgG2a, κ Human lymphoblastoid B cell line RPMI 8866.9
BE0306-5MG InVivoMAb anti-human/monkey MHC class II (HLA-DR) L243 human/monkey MHC class II (HLA-DR) Mouse IgG2a, κ Human lymphoblastoid B cell line RPMI 8866.9
BE0306-25MG InVivoMAb anti-human/monkey MHC class II (HLA-DR) L243 human/monkey MHC class II (HLA-DR) Mouse IgG2a, κ Human lymphoblastoid B cell line RPMI 8866.9
BE0306-50MG InVivoMAb anti-human/monkey MHC class II (HLA-DR) L243 human/monkey MHC class II (HLA-DR) Mouse IgG2a, κ Human lymphoblastoid B cell line RPMI 8866.9
BE0307-100MG InVivoMAb anti-mouse CD16/CD32 2.4G2 mouse CD16/CD32 Rat IgG2b, κ BALB/c mouse macrophage cell line J774
BE0307-5MG InVivoMAb anti-mouse CD16/CD32 2.4G2 mouse CD16/CD32 Rat IgG2b, κ BALB/c mouse macrophage cell line J774
BE0307-25MG InVivoMAb anti-mouse CD16/CD32 2.4G2 mouse CD16/CD32 Rat IgG2b, κ BALB/c mouse macrophage cell line J774
BE0307-50MG InVivoMAb anti-mouse CD16/CD32 2.4G2 mouse CD16/CD32 Rat IgG2b, κ BALB/c mouse macrophage cell line J774
BE0308-100MG InVivoMAb anti-rat CD4 OX-38 rat CD4 Mouse IgG2a, κ Rat thymocyte glycoproteins
BE0308-1MG InVivoMAb anti-rat CD4 OX-38 rat CD4 Mouse IgG2a, κ Rat thymocyte glycoproteins
BE0308-5MG InVivoMAb anti-rat CD4 OX-38 rat CD4 Mouse IgG2a, κ Rat thymocyte glycoproteins
BE0308-25MG InVivoMAb anti-rat CD4 OX-38 rat CD4 Mouse IgG2a, κ Rat thymocyte glycoproteins
BE0308-50MG InVivoMAb anti-rat CD4 OX-38 rat CD4 Mouse IgG2a, κ Rat thymocyte glycoproteins
BE0309-100MG InVivoMAb anti-mouse CXCL9 (MIG) MIG-2F5.5 mouse CXCL9 (MIG) Armenian hamster IgG, κ
BE0309-1MG InVivoMAb anti-mouse CXCL9 (MIG) MIG-2F5.5 mouse CXCL9 (MIG) Armenian hamster IgG, κ
BE0309-5MG InVivoMAb anti-mouse CXCL9 (MIG) MIG-2F5.5 mouse CXCL9 (MIG) Armenian hamster IgG, κ
BE0309-25MG InVivoMAb anti-mouse CXCL9 (MIG) MIG-2F5.5 mouse CXCL9 (MIG) Armenian hamster IgG, κ
BE0309-50MG InVivoMAb anti-mouse CXCL9 (MIG) MIG-2F5.5 mouse CXCL9 (MIG) Armenian hamster IgG, κ
BE0310-100MG InVivoMAb anti-mouse VISTA 13F3 mouse VISTA Armenian hamster IgG EL4 cells overexpressing mouse VISTA-RFP ａnd then boosted with VISTA-Ig fusion protein
BE0310-1MG InVivoMAb anti-mouse VISTA 13F3 mouse VISTA Armenian hamster IgG EL4 cells overexpressing mouse VISTA-RFP ａnd then boosted with VISTA-Ig fusion protein
BE0310-5MG InVivoMAb anti-mouse VISTA 13F3 mouse VISTA Armenian hamster IgG EL4 cells overexpressing mouse VISTA-RFP ａnd then boosted with VISTA-Ig fusion protein
BE0310-25MG InVivoMAb anti-mouse VISTA 13F3 mouse VISTA Armenian hamster IgG EL4 cells overexpressing mouse VISTA-RFP ａnd then boosted with VISTA-Ig fusion protein
BE0310-50MG InVivoMAb anti-mouse VISTA 13F3 mouse VISTA Armenian hamster IgG EL4 cells overexpressing mouse VISTA-RFP ａnd then boosted with VISTA-Ig fusion protein
BE0311-100MG InVivoMAb anti-mouse CD317 (BST2, PDCA-1) 927 mouse CD317 (BST2, PDCA-1) Rat IgG2b, κ Mouse type I IFN-producing cells
BE0311-1MG InVivoMAb anti-mouse CD317 (BST2, PDCA-1) 927 mouse CD317 (BST2, PDCA-1) Rat IgG2b, κ Mouse type I IFN-producing cells
BE0311-5MG InVivoMAb anti-mouse CD317 (BST2, PDCA-1) 927 mouse CD317 (BST2, PDCA-1) Rat IgG2b, κ Mouse type I IFN-producing cells
BE0311-25MG InVivoMAb anti-mouse CD317 (BST2, PDCA-1) 927 mouse CD317 (BST2, PDCA-1) Rat IgG2b, κ Mouse type I IFN-producing cells
BE0311-50MG InVivoMAb anti-mouse CD317 (BST2, PDCA-1) 927 mouse CD317 (BST2, PDCA-1) Rat IgG2b, κ Mouse type I IFN-producing cells
BE0312-100MG InVivoMAb anti-mouse IFNγ H22 mouse IFNγ Armenian hamster IgG Recombinant full-length murine IFNγ
BE0312-1MG InVivoMAb anti-mouse IFNγ H22 mouse IFNγ Armenian hamster IgG Recombinant full-length murine IFNγ
BE0312-5MG InVivoMAb anti-mouse IFNγ H22 mouse IFNγ Armenian hamster IgG Recombinant full-length murine IFNγ
BE0312-25MG InVivoMAb anti-mouse IFNγ H22 mouse IFNγ Armenian hamster IgG Recombinant full-length murine IFNγ
BE0312-50MG InVivoMAb anti-mouse IFNγ H22 mouse IFNγ Armenian hamster IgG Recombinant full-length murine IFNγ
BE0313-100MG InVivoMAb anti-mouse IL-23 (p19) G23-8 mouse IL-23 (p19) Rat IgG1, κ Insect cell-expressed, recombinant mouse IL-23 heterodimer
BE0313-25MG InVivoMAb anti-mouse IL-23 (p19) G23-8 mouse IL-23 (p19) Rat IgG1, κ Insect cell-expressed, recombinant mouse IL-23 heterodimer
BE0313-50MG InVivoMAb anti-mouse IL-23 (p19) G23-8 mouse IL-23 (p19) Rat IgG1, κ Insect cell-expressed, recombinant mouse IL-23 heterodimer
BE0314-100MG InVivoMAb anti-mouse TIM-1 (CD365) 3D10 mouse TIM-1 (CD365) Rat IgG1, κ Mouse TIM-1 (signal ａnd IgV domains)/mouse IgG2a Fc fusion protein
BE0314-1MG InVivoMAb anti-mouse TIM-1 (CD365) 3D10 mouse TIM-1 (CD365) Rat IgG1, κ Mouse TIM-1 (signal ａnd IgV domains)/mouse IgG2a Fc fusion protein
BE0314-5MG InVivoMAb anti-mouse TIM-1 (CD365) 3D10 mouse TIM-1 (CD365) Rat IgG1, κ Mouse TIM-1 (signal ａnd IgV domains)/mouse IgG2a Fc fusion protein
BE0314-25MG InVivoMAb anti-mouse TIM-1 (CD365) 3D10 mouse TIM-1 (CD365) Rat IgG1, κ Mouse TIM-1 (signal ａnd IgV domains)/mouse IgG2a Fc fusion protein
BE0314-50MG InVivoMAb anti-mouse TIM-1 (CD365) 3D10 mouse TIM-1 (CD365) Rat IgG1, κ Mouse TIM-1 (signal ａnd IgV domains)/mouse IgG2a Fc fusion protein
BE0315-100MG InVivoMAb anti-mouse IL-15 AIO.3 mouse IL-15 Rat IgG2a, κ Recombinant mouse IL-15
BE0315-25MG InVivoMAb anti-mouse IL-15 AIO.3 mouse IL-15 Rat IgG2a, κ Recombinant mouse IL-15
BE0315-50MG InVivoMAb anti-mouse IL-15 AIO.3 mouse IL-15 Rat IgG2a, κ Recombinant mouse IL-15
BE0316-100MG InVivoMAb anti-mouse CCR3 (CD193) 6S2-19-4 mouse CCR3 (CD193) Rat IgG2b, λ Y3 cells expressing full length mouse CCR3
BE0316-1MG InVivoMAb anti-mouse CCR3 (CD193) 6S2-19-4 mouse CCR3 (CD193) Rat IgG2b, λ Y3 cells expressing full length mouse CCR3
BE0316-5MG InVivoMAb anti-mouse CCR3 (CD193) 6S2-19-4 mouse CCR3 (CD193) Rat IgG2b, λ Y3 cells expressing full length mouse CCR3
BE0316-25MG InVivoMAb anti-mouse CCR3 (CD193) 6S2-19-4 mouse CCR3 (CD193) Rat IgG2b, λ Y3 cells expressing full length mouse CCR3
BE0316-50MG InVivoMAb anti-mouse CCR3 (CD193) 6S2-19-4 mouse CCR3 (CD193) Rat IgG2b, λ Y3 cells expressing full length mouse CCR3
BE0317-100MG InVivoMAb anti-mouse CD38 NIMR5 mouse CD38 Rat IgG2a, κ BCL1 plasma membrane glycoproteins
BE0317-1MG InVivoMAb anti-mouse CD38 NIMR5 mouse CD38 Rat IgG2a, κ BCL1 plasma membrane glycoproteins
BE0317-5MG InVivoMAb anti-mouse CD38 NIMR5 mouse CD38 Rat IgG2a, κ BCL1 plasma membrane glycoproteins
BE0317-25MG InVivoMAb anti-mouse CD38 NIMR5 mouse CD38 Rat IgG2a, κ BCL1 plasma membrane glycoproteins
BE0317-50MG InVivoMAb anti-mouse CD38 NIMR5 mouse CD38 Rat IgG2a, κ BCL1 plasma membrane glycoproteins
BE0318-100MG InVivoMAb anti-human Ganglioside GD2 14G2a human Ganglioside GD2 Mouse IgG2a, κ Neuroblastoma cell line LAN-1
BE0318-1MG InVivoMAb anti-human Ganglioside GD2 14G2a human Ganglioside GD2 Mouse IgG2a, κ Neuroblastoma cell line LAN-1
BE0318-5MG InVivoMAb anti-human Ganglioside GD2 14G2a human Ganglioside GD2 Mouse IgG2a, κ Neuroblastoma cell line LAN-1
BE0318-25MG InVivoMAb anti-human Ganglioside GD2 14G2a human Ganglioside GD2 Mouse IgG2a, κ Neuroblastoma cell line LAN-1
BE0318-50MG InVivoMAb anti-human Ganglioside GD2 14G2a human Ganglioside GD2 Mouse IgG2a, κ Neuroblastoma cell line LAN-1

浓度：2-10 mg/m

l

储存与安全
储存:
4℃
抗体,,Bioxcell,invivo,MAb,anti-mouse,

采购记录

优质供应

相关产品

相关文章

我要推广

优质信息推广广告
  • 友情链接
  • 热词推荐

生物原料自研、加工与量产业务 生物领域技术开发与配套技术服务 生物相关产品销售流通业务 进出口经营业务 合规生物制品加工生产

展台首页|供应产品|产品分类|优质仪器|公司动态|技术文章|咨询留言|联系我们|会员管理

阿仪网会员推广咨询：18158115302 （微信同号），VIP会员、建站、优化排名等业务咨询

阿仪网 设计制作，未经允许复制必究.Copyright(C) 2009 https://www.app17.com, All rights reserved.

以上信息由企业自行提供，信息内容的真实性、准确性和合法性由相关企业负责，阿仪网对此不承担任何责任。

微信客服二维码
在线咨询5分钟应答

提交